Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1996 Jan;74(1):64–65. doi: 10.1136/adc.74.1.64

Thalidomide treatment of mucosal ulcerations in HIV infection.

R A Solèr 1, C Migliorati 1, H van Waes 1, D Nadal 1
PMCID: PMC1511591  PMID: 8660053

Abstract

Pain relief and resolution of oral and perianal ulceration after treatment with thalidomide in a 14 year old girl with vertically acquired HIV infection is reported.

Full text

PDF
64

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. MacPhail L. A., Greenspan D., Greenspan J. S. Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment. Oral Surg Oral Med Oral Pathol. 1992 Mar;73(3):283–288. doi: 10.1016/0030-4220(92)90122-7. [DOI] [PubMed] [Google Scholar]
  2. McHugh S. M., Rifkin I. R., Deighton J., Wilson A. B., Lachmann P. J., Lockwood C. M., Ewan P. W. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol. 1995 Feb;99(2):160–167. doi: 10.1111/j.1365-2249.1995.tb05527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Moreira A. L., Sampaio E. P., Zmuidzinas A., Frindt P., Smith K. A., Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med. 1993 Jun 1;177(6):1675–1680. doi: 10.1084/jem.177.6.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Paterson D. L., Georghiou P. R., Allworth A. M., Kemp R. J. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis. 1995 Feb;20(2):250–254. doi: 10.1093/clinids/20.2.250. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES